Przyklenk K, Kloner R A
Basic Res Cardiol. 1987 Mar-Apr;82(2):146-58. doi: 10.1007/BF01907062.
Oxygen-derived free radicals (O-2 and .OH) have been implicated in myocardial injury associated with coronary artery occlusion followed by reperfusion. While these cytotoxic oxygen species are predominantly produced upon reintroduction of molecular oxygen to previously ischemic tissue, they may also be generated throughout coronary occlusion in species (such as dog and man) in which native collateral vessels permit residual blood flow into the ischemic bed. To test this theory, 20 anesthetized, open-chest dogs underwent 6 h of permanent left anterior descending coronary artery occlusion: ten dogs were treated with the potent free radical scavenging enzymes superoxide dismutase (SOD: 5 mg/kg per hour) plus catalase (5 mg/kg per hour), while the remaining ten animals received saline. Infusion of drug or saline solution was begun 15 min prior to occlusion, and maintained throughout occlusion. Infusion of SOD + catalase did not significantly affect the extent of the area at risk of infarction (19.5 +/- 1.8% vs 24.0 +/- 1.4% of the left ventricle for the treated vs control group; P = NS), did not reduce myocardial oxygen demand (heart rate and arterial pressures were comparable for both groups), and did not alter collateral blood flow to the ischemic myocardium. However, mean infarct size in dogs treated with SOD + catalase (39.6 +/- 6.6% of the area at risk; 8.4 +/- 2.1% of the left ventricle) was significantly smaller than that observed in the saline controls (73.0 +/- 6.3% of the area at risk, P less than 0.01; 19.8 +/- 2.2% of the left ventricle, P less than 0.01). Thus, infusion of SOD + catalase prior to and during 6 h of coronary occlusion significantly reduced infarct size assessed at 6 h postocclusion. To determine whether this reduction in infarct size represented long-term salvage of ischemic myocardium, an additional 14 dogs (seven treated and seven controls) underwent the same procedure as described above; in this case the artery was reperfused after the 6-hour occlusion period, infusion of the SOD + catalase or saline solution stopped at 5-10 min postreperfusion, and the hearts examined at 30-48 h postocclusion. In contrast to the results at 6 h postocclusion, the necrosis at 30-48 h postocclusion was large, confluent and transmural in all dogs (infarct size = 21.2 +/- 2.5% vs 22.7 +/- 4.4% of the left ventricle for treated vs controls; P = NS). These results suggest that infusion of SOD + catalase in this model may delay, but not prevent, the development of ischemic necrosis.
氧衍生的自由基(O₂和·OH)被认为与冠状动脉闭塞后再灌注相关的心肌损伤有关。虽然这些具有细胞毒性的氧物质主要是在向先前缺血的组织重新引入分子氧时产生的,但在天然侧支血管允许残余血流进入缺血区的物种(如狗和人)中,它们也可能在整个冠状动脉闭塞期间产生。为了验证这一理论,对20只麻醉开胸犬进行了6小时的左前降支冠状动脉永久性闭塞:10只犬用强效自由基清除酶超氧化物歧化酶(SOD:每小时5mg/kg)加过氧化氢酶(每小时5mg/kg)治疗,其余10只动物接受生理盐水。在闭塞前15分钟开始输注药物或生理盐水,并在整个闭塞过程中维持。输注SOD +过氧化氢酶并没有显著影响梗死危险区的范围(治疗组与对照组分别为左心室的19.5±1.8%和24.0±1.4%;P =无显著性差异),没有降低心肌需氧量(两组的心率和动脉压相当),也没有改变向缺血心肌的侧支血流。然而用SOD +过氧化氢酶治疗的犬的平均梗死面积(梗死危险区的39.6±6.6%;左心室的8.4±2.1%)明显小于生理盐水对照组(梗死危险区的百分之73.0±百分之6.3,P<0.01;左心室的19.8±2.2%,P<0.01)。因此,在冠状动脉闭塞6小时之前和期间输注SOD +过氧化氢酶可显著减小闭塞后6小时评估的梗死面积。为了确定梗死面积的减小是否代表缺血心肌的长期挽救,另外14只犬(7只治疗组和7只对照组)进行了上述相同的手术;在这种情况下,在6小时闭塞期后进行动脉再灌注,在再灌注后5 - 10分钟停止输注SOD +过氧化氢酶或生理盐水,并在闭塞后30 - 48小时检查心脏。与闭塞后6小时的结果相反,所有犬在闭塞后30 - 48小时的坏死范围大、融合且透壁(治疗组与对照组梗死面积分别为左心室的21.2±2.5%和22.7±4.4%;P =无显著性差异)。这些结果表明,在该模型中输注SOD +过氧化氢酶可能会延迟但不能预防缺血性坏死的发展。